Related Articles
Association between increased mutation rates in DNMT3Α and FLT3‑ITD and poor prognosis of patients with acute myeloid leukemia
Haematopoietic cytokines in the biology and treatment of acute myeloid leukaemia
Novel AXL‑targeted agents overcome FLT3 inhibitor resistance in FLT3‑ITD+ acute myeloid leukemia cells
<em>In silico</em> and<em> in vitro</em> study of FLT3 inhibitors and their application in acute myeloid leukemia
Prognosis and outcome of patients with acute myeloid leukemia based on FLT3‑ITD mutation with or without additional abnormal cytogenetics